Martial Moonen

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

Glomerulonephritis, Active-controlled Clinical Trial, Renal Function +9

Dephosphorylated-uncarboxylated Matrix Gla protein concentration is predictive of vitamin K status and is correlated with vascular calcification in a cohort of hemodialysis patients

Pierre Delanaye, Jean-Marie Krzesinski, Xavier Warling et al. · BMC Nephrology · 2014 · 115 citations · Full text

Cholecalciferol in haemodialysis patients: a randomized, double-blind, proof-of-concept and safety study

Pierre Delanaye, Laurent Weekers, Xavier Warling et al. · Nephrology Dialysis Transplantation · 2013 · 77 citations · Full text

Clinical and Biological Determinants of Sclerostin Plasma Concentration in Hemodialysis Patients

Pierre Delanaye, Jean-Marie Krzesinski, Xavier Warling et al. · Nephron Clinical Practice · 2014 · 61 citations